Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaNaval Daver, Yanis Boumber, Hagop Kantarjian, et al.
Plos One|December 2, 2011
DNA methylation profiles of primary colorectal carcinoma and matched liver metastasisKazuo Konishi, Yoshiyuki Watanabe, Lanlan Shen, et al.
Oncogenesis|March 16, 2021
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)Petr Makhov, Igor Bychkov, Bulat Faezov, et al.
International Journal of Cancer|February 5, 2010
Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancersByonggu An, Yutaka Kondo, Yasuyuki Okamoto, et al.
Nature Genetics|December 6, 2011
Dnmt3a is essential for hematopoietic stem cell differentiationGrant A Challen, Deqiang Sun, Mira Jeong, et al.
Genome Biology|December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionGabriel G Malouf, Joseph H Taube, Yue Lu, et al.
The Lancet. Oncology|August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 studyJean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
Scientific Reports|September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesJoseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Research|November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinomaYasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
Pageof 25